Gilead Sciences
GILD
#130
Rank
$162.11 B
Marketcap
$130.57
Share price
-0.54%
Change (1 day)
13.78%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): $10.72 Billion USD

According to Gilead Sciences's latest financial reports the company's current earnings are $29.73 Billion USD. In 2025 the company made an earning of $9.79 Billion USD, an increase over its 2024 earnings that were of $0.69 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $10.72 B9.5%
2025 $9.79 B1319.86%
2024 $0.69 B-89.94%
2023 $6.85 B17.97%
2022 $5.81 B-29.77%
2021 $8.27 B395.99%
2020 $1.66 B-67.66%
2019 $5.16 B-33.84%
2018 $7.79 B-42.35%
2017 $13.52 B-20.87%
2016 $17.09 B-21.06%
2015 $21.65 B45.8%
2014 $14.85 B253.01%
2013 $4.20 B16.51%
2012 $3.61 B-1.07%
2011 $3.65 B-6.71%
2010 $3.91 B11.75%
2009 $3.50 B29.5%
2008 $2.70 B19.11%
2007 $2.27 B-455.74%
2006 -$0.64 Billion-154.93%
2005 $1.16 B76.99%
2004 $0.65 B-266.16%
2003 -$0.4 Billion-638.24%
2002 $73.39 M31.5%
2001 $55.81 M-242.15%
2000 -$39.27 Million-40.2%
1999 -$65.67 Million31.85%
1998 -$49.8 Million8.73%
1997 -$45.8 Million27.22%
1996 -$36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B 142.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$10.59 B-1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$5.97 B-44.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$31.12 B 190.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.08 B-15.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$1.62 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$1.16 B-89.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$5.06 B-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$13.15 B 22.60%๐Ÿ‡บ๐Ÿ‡ธ USA